Skip to main content
Signal8

Full Access with Signal8 Pro, $49/mo billed annually.

Important Notice to Long-Term Shareholders of Erasca, Inc. (NASDAQ: ERAS); Insulet Corporation (NASDAQ: PODD); Power Solutions International, Inc. (NASDAQ: PSIX); and PROCEPT BioRobotics Corporation (NASDAQ: PRCT): Grabar Law Office is Investigating Claims on Your Behalf

$ERASPress releaseAug 7, 2026, 9:32 AM ETRead the release

Grabar Law Office issued a solicitation notice for Erasca shareholders, alleging breaches of fiduciary duty related to disclosures about drug candidate ERAS-0015. The investigation centers on claims that Erasa made misleading comparisons between ERAS-0015 and Revolution Medicines' RMC-6236, and failed to adequately disclose IP risks and a patient death in a Phase 1 trial.

AI analysis

The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.

AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.